期刊文献+

D-脯氨酸催化的(3S,4S)-4-氨基-3-羟基-5-苯基戊酸衍生物的合成

Synthesis of (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic Acid Derivatives Catalyzed by D-proline
下载PDF
导出
摘要 报道了一条合成(3S,4S)-4-氨基-3-羟基-5-苯基戊酸(Ahppa)衍生物的新路线。以氨基保护的L-苯丙氨酸为起始原料,依次经Weinreb胺缩合、还原、aldol缩合及溴仿4步反应合成了3个Ahppa衍生物,总收率5.8%-6.7%,其结构经^1H NMR,^13C NMR和ESI-MS确证。对反应条件进行了探讨,结果表明:催化剂D-脯氨酸用量对反应收率影响不大,对立体选择性影响较大;氨基上保护基体积较大有利于提高反应立体选择性。 A new route for the synthesis of (3S ,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid derivatives was reported. The target compounds with overall yields of 5.8% - 6.7% were synthesized by condensation with Weinreb amide, reduction, aldol condensation reaction and bromine imitation reaction, using amino-protected L-phenylalanine as starting material. The structures were confirmed by ^1H NMR, ^13C NMR and ESI-MS. The exploration of reaction conditions showed that the loading amount of D-proline had no evident effect on the yield, but on stereoselectivity. Larger size protecting groups in substrate can enhanced the stereo-selectivity.
出处 《合成化学》 CAS CSCD 2016年第4期355-358,共4页 Chinese Journal of Synthetic Chemistry
基金 国家自然科学基金资助项目(81573340) 复旦大学卓学人才计划资助项目
关键词 苯丙氨酸 天冬氨酸蛋白酶抑制剂 (3S 4S)-4-氨基-3-羟基-5-苯基戊酸 D-脯氨酸 催化 药物合成 phenylalanine aspartie protease inhibitor (3S,4S) -4-amino-3-hydroxy-5-phenylpentanoic acid D-proline catalysis drug synthesis
  • 相关文献

参考文献12

  • 1Leanna M R, DeMattei J A, et al. Synthesis of the C- 13 side chain precursors of the 9-dihydrotaxane ana- logue ABT-271 [J]. Org I.ett,2000,2(23) :3627 -3630.
  • 2徐文方,郁有农.氨肽酶抑制剂bestatin及其衍生物的研究进展[J].国外医药(合成药.生化药.制剂分册),1998,19(3):138-143. 被引量:2
  • 3Stratmann K, Burgoyne D L, Moore R E, et al. Hapa- losin, a cyanobacterial cyclic depsipeptide with multi- drug-resistance reversing activity [ J ]. J Org Chem, 1994,59 (24) : 7219 - 7226.
  • 4Kalemkerian G P, Ou X, Adil M R, et al. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo:Induction of apoptosis and bcl-2 modification [ J ]. Cancer Chemoth Pharm, 1999,43 (6) :507 - 515.
  • 5Rinehart K L, Gloer J B, Cook J C, et al. Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate [J]. J Am Chem Soe,1981, 103(7) :1857 - 1859.
  • 6Umezawa H, Aoyagi T, Morishima H, et al. Pepsta- tin, a new pepsin inhibit or produced by Actinomycetes [ J ]. J Antibiot, 1970,23 : 259 - 262.
  • 7Boger J, Payne L S, Perlow D S, et al. Renin inhibi- tots. syntheses of subnanomolar, competitive, transtion- state analog inhibitors containing a novel analog of sta- tine[ J]. J Med Chem,1985,2,8(12) :1779 - 1790.
  • 8Kunimoto S, Aoyagi T, Nishizawa R, et al. Mecha- nism of inhibition of pepsin by pepstatin. II[ J]. J Anti- biot,1974,27:413-418.
  • 9Martin E M, Christoph H. Synthesis of the 3,-amino-fl- hydroxy acid of hapalosin via an asymmetric dihydroxy- lation route [ J ]. Tetrahedron,2000 ,56:557 - 561.
  • 10Kondekar N B, Kandula R S V, Kumar P. Applica- tion of the asymmetric aminohydroxylation reaction for the syntheses of HIV-protease inhibitor, hydmxyethyl- ene dipeptide isostere and c-amino acid derivative [ J ]. Tetrahedron Lett, 2004,45:5477 - 5479.

二级参考文献2

  • 1Henric Blomgren,Ingemar N?slund,Pier-Luigi Esposti,Lise Johansen,Ove Aaskoven. Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder[J] 1987,Cancer Immunology Immunotherapy(1):41~46
  • 2Kazuo Ota,Soji Kurita,Kazumasa Yamada,Tohru Masaoka,Yoshiro Uzuka,Nobuya Ogawa. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults[J] 1986,Cancer Immunology Immunotherapy(1):5~10

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部